In this free webinar, see perspectives on the impact of rising clinical trial complexity across all stakeholders, especially in Rare Disease. Attendees will learn about designing trials with and...

In this free webinar, gain practical insights into designing fit-for-purpose operating models that are in tune with clinical development goals and set up clinical programs for success. Attendees...

Promethean®, a leading global tech company and brand owned by Mynd.ai, Inc. (NYSE American: MYND) is bringing its award-winning interactive displays and software to InfoComm 2026, the largest...

Diebold Nixdorf (NYSE: DBD), a world leader in transforming the way people bank and shop, today announced Octavio Marquez, president and chief executive officer, and Tom Timko, executive vice...

Halia Therapeutics, Inc., The Genetic Resilience Company™, a clinical-stage biopharmaceutical company advancing first-in-class inflammation therapies anchored in protective human genetics, today...